van Breeschoten J, Wouters MWJM, Hilarius DL, Haanen JB, et al. Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis. Br J Cancer 2022 Mar 7. pii: 10.1038/s41416-022-01772.
PMID: 35256756